RSV vaccines safe and effective, Cochrane review finds
Peer-Reviewed Publication
Updates every hour. Last Updated: 28-Dec-2025 18:11 ET (28-Dec-2025 23:11 GMT/UTC)
A new Cochrane review demonstrates that vaccines for respiratory syncytial virus (RSV) are both safe and effective in protecting vulnerable groups that are most at risk of serious illness, including older adults and infants.
A research paper by scientists at The University of New South Wales presented a new hydraulic-driven dual soft robotic system featuring a 3 DOF-soft cutting arm (SCA) and a 3-jaw teleoperated soft grasper system (TSGS).
The research paper was published on Jun. 12, 2025 in the journal Cyborg and Bionic Systems.
A new review by a public health expert from the Hebrew University of Jerusalem reveals that finasteride, a common hair-loss drug, has been linked to depression and suicide for over two decades — yet regulators and manufacturers failed to act. Drawing on data from adverse event reports and healthcare records around the world, the study shows consistent psychiatric harm associated with the drug. Despite mounting evidence, neither Merck nor the FDA initiated critical safety studies. The author calls for urgent reform in how medications are monitored and approved.